Works matching IS 03065251 AND DT 2003 AND VI 55 AND IP 5
1
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 453, doi. 10.1046/j.1365-2125.2003.01837.x
- Article
2
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 451, doi. 10.1046/j.0306-5251.2003.01838.x
- Article
3
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 458, doi. 10.1046/j.1365-2125.2003.01839.x
- Article
4
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 483, doi. 10.1046/j.1365-2125.2003.01840.x
- Article
5
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 477, doi. 10.1046/j.1365-2125.2003.01841.x
- Article
6
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 469, doi. 10.1046/j.1365-2125.2003.01842.x
- Article
7
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 473, doi. 10.1046/j.1365-2125.2003.01843.x
- Back, David J.;
- Khoo, Saye H.
- Article
8
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 460, doi. 10.1046/j.1365-2125.2003.01844.x
- Article
9
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 464, doi. 10.1046/j.1365-2125.2003.01845.x
- Article
10
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 480, doi. 10.1046/j.1365-2125.2003.01846.x
- Article
11
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 5, p. 486, doi. 10.1046/j.1365-2125.2003.01847.x
- Pirmohamed, Munir;
- Park, B. Kevin
- Article